Skip to main content

Study M1034

Study name

Chojnacki C 2023a

Title

Changes in tryptophan metabolism on serotonin and kynurenine pathways in patients with irritable bowel syndrome

Overall design

The aim of this study was to evaluate the urinary excretion of selected tryptophan metabolites in patients with constipation-predominant and diarrhoea-predominant irritable bowel syndrome, related to somatic and mental symptoms. The study involved 40 healthy people (control group), 40 patients with small intestinal bacterial overgrowth and chronic diarrhea (small intestinal bacterial overgrowth and chronic diarrhea group), and 40 patients with small intestinal bacterial overgrowth and chronic constipation (small intestinal bacterial overgrowth and chronic constipation group). The concentrations of tryptophan and its metabolites in urine were determined using an LC-MS/MS method.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive symptom; Depressive symptom with comorbidity; Depressive symptom with comorbidity;

Criteria for depression

Not reported

Sample size

120

Tissue

Peripheral; Urine; Urine;

Platform

MS-based; LC-MS: not reported;

PMID

36904262

DOI

10.3390/nu15051262

Citation

Chojnacki C, Blonska A, Konrad P, et al. Changes in tryptophan metabolism on serotonin and kynurenine pathways in patients with irritable bowel syndrome. Nutrients. 2023 Mar 3;15(5):1262.

Metabolite

5-Hydroxyindoleacetic acid;

L-Kynurenine;

Kynurenic acid;

Quinolinic acid;